507 related articles for article (PubMed ID: 9219900)
1. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
2. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation.
Marshall LA; Bolognese B; Roshak A
Adv Exp Med Biol; 1999; 469():215-9. PubMed ID: 10667333
[TBL] [Abstract][Full Text] [Related]
3. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
4. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Shamsuddin M; Chen E; Anderson J; Smith LJ
J Lab Clin Med; 1997 Dec; 130(6):615-26. PubMed ID: 9422335
[TBL] [Abstract][Full Text] [Related]
5. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
6. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
7. Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.
Marshall LA; Bolognese B; Winkler JD; Roshak A
J Biol Chem; 1997 Jan; 272(2):759-65. PubMed ID: 8995361
[TBL] [Abstract][Full Text] [Related]
8. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
9. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
[TBL] [Abstract][Full Text] [Related]
10. Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.
Winkler JD; Fonteh AN; Sung CM; Heravi JD; Nixon AB; Chabot-Fletcher M; Griswold D; Marshall LA; Chilton FH
J Pharmacol Exp Ther; 1995 Sep; 274(3):1338-47. PubMed ID: 7562506
[TBL] [Abstract][Full Text] [Related]
11. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
[TBL] [Abstract][Full Text] [Related]
12. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2.
Billah MM; Bryant RW; Siegel MI
J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982
[TBL] [Abstract][Full Text] [Related]
13. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
14. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
Flamand N; Picard S; Lemieux L; Pouliot M; Bourgoin SG; Borgeat P
Br J Pharmacol; 2006 Oct; 149(4):385-92. PubMed ID: 16967052
[TBL] [Abstract][Full Text] [Related]
15. Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils.
Naraba H; Imai Y; Kudo I; Nakagawa Y; Oh-ishi S
J Biochem; 1995 Aug; 118(2):442-7. PubMed ID: 8543583
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools.
Fonteh AN
Eur J Biochem; 2002 Aug; 269(15):3760-70. PubMed ID: 12153573
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrophils.
Chilton FH; Fonteh AN; Sung CM; Hickey DM; Torphy TJ; Mayer RJ; Marshall LA; Heravi JD; Winkler JD
Biochemistry; 1995 Apr; 34(16):5403-10. PubMed ID: 7727398
[TBL] [Abstract][Full Text] [Related]
19. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
[TBL] [Abstract][Full Text] [Related]
20. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway.
Uemura Y; Lee TC; Snyder F
J Biol Chem; 1991 May; 266(13):8268-72. PubMed ID: 2022643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
